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Computational modeling and fluorescence microscopy 
characterization of a two-phase magnetophoretic microsystem for 
continuous-flow blood detoxification 
Jenifer Gómez-Pastora,a Cristina González-Fernández,a Eusebio Real,b Alexander Iles,c Eugenio 
Bringas,a Edward P. Furlani,d,e and Inmaculada Ortiz*a 
Magnetic beads can be functionalized to capture and separate target pathogens from blood for extracorporeal 
detoxification. The beads can be magnetically separated from a blood stream and collected into a coflowing buffer solution 
using a two-phase liquid-liquid continuous-flow microfluidic device in the presence of an external field. However, device 
design and process optimization, i.e. high bead recovery with minimum blood loss or dilution remain a substantial 
technological challenge. We introduce a CFD-based Eulerian-Lagrangian computational model that enables the rational 
design and optimization of such systems. The model takes into account dominant magnetic and hydrodynamic forces on the 
beads as well as coupled bead-fluid interactions. Fluid flow (Navier-Stokes equations) and mass transfer (Fick’s Law) between 
the coflowing fluids are solved numerically, while the magnetic force on the beads is predicted using analytical methods. 
The model is demonstrated via application to a prototype device and used to predict key performance metrics; degree of 
bead separation, flow patterns, and mass transfer, i.e. blood diffusion to the buffer phase. The impact of different process 
variables and parameters – flowrates, bead and magnet dimensions and fluid viscosities – on both bead recovery and blood 
loss or dilution is quantified for the first time. The performance of the prototype device is characterized using fluorescence 
microscopy and the experimental results are found to match theoretical predictions within an absolute error of 15%. While 
the model is demonstrated here for analysis of a detoxification device, it can be readily adapted to a broad range of 
magnetically-enabled microfluidic applications, e.g. bioseparation, sorting and sensing.
Introduction 
The separation and detection of biomaterials from complex media 
such as biological fluids is fundamental and often challenging in 
multiple areas within biology, biotechnology and medicine.1,2 The 
removal of toxic substances from blood (biotoxins, microorganisms, 
heavy metals, radioactive toxins or drugs) is of particular interest 
since their presence in the bloodstream can cause deleterious 
metabolic alterations and even death.3-5 The removal of the disease-
causing agents from blood can be considered as the most direct 
treatment for different clinical conditions such as intoxication, 
bacteraemia or autoimmune diseases.6,7 Among the different 
extracorporeal methods, the use of functionalized magnetic beads as 
toxin sequestering agents has been considered one of the best 
alternatives since it can improve the effectiveness of the treatment 
while reducing adverse side effects.4 The interest in extracorporeal 
detoxification with magnetic beads stems from the limitations of the 
traditional methods (hemodialysis, hemofiltration, plasmapheresis, 
extracorporeal imunoadsorption, direct injection of chelators and 
antibodies, etc.).8,9 Furthermore, advances in magnetic bead 
synthesis and functionalization enable multiple surface decorations 
that can be tailored to bind with a broad variety of blood borne 
pathogens.10-15  
Extracorporeal blood detoxification using functionalized magnetic 
beads is a two-stage process as seen in Fig. 1. First, the beads are 
mixed with blood taken from the patient and selectively bind with 
target toxins thereby forming toxin-bead complexes within the 
blood. In the second stage, the toxin-bead complexes are 
magnetically separated from the blood and the resulting toxin-free 
blood solution is returned to the patient’s circulatory system. The 
ultimate goal of this process is to selectively remove pathogens from 
a patient’s blood without altering blood constituents and function. 
Numerous magnetophoretic microseparators have been designed 
for the recovery of magnetic beads from biological fluids.16-20 
Recently, some studies have demonstrated the advantages of two-
phase continuous-flow separators, where the beads are deflected 
from the blood stream and collected into a separate coflowing buffer 
solution by a magnetic force applied perpendicular to the flow 
direction.21 However, the complexity of these systems is high and 
many design challenges exist that need to be addressed. 
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Fig. 1 Schematic illustrating extracorporeal blood detoxification and 
bead magnetophoresis from a flowing blood stream to a coflowing 
buffer solution in the microdevice. 
 
For example, Lee and coworkers22 employed a dual inlet microfluidic 
system for the removal of magnetic nanoparticles (attached to E. 
Coli) from bovine blood, and although 25% of the bacteria was 
collected in a saline buffer, they found difficulties in maintaining two 
symmetric laminar flows because the difference between the saline 
and blood viscosities was very large (1 cP for saline and 10 cP for 
blood). To address this problem, they employed a single-inlet, dual-
outlet device, where blood was infused and the particles remained 
trapped at the walls (i.e. a batch device). Yung et al.23 employed a 
similar design for the separation of fungi from blood, and although 
they cleared 80% of bead-bound-fungi, significant blood loss (50-
60%) was observed when the flow rates of both solutions (aqueous 
PBS and whole blood) were the same. The use of a more viscous 
solution as the buffer did not improve the phase separation, but 
instead, by modifying the flowrate ratio between the two fluids the 
blood loss was reduced. 
On the other hand, Kang et al.24 employed a two-phase microfluidic 
channel to separate bacteria attached to magnetic nanoparticles 
(128 nm) and found serious difficulties in recovering all the particles 
at relatively high velocities (80%). Although these authors did not 
observe blood dilution or loss, their particles were very small to 
obtain an adequate separation and thus, they had to add to their 
system micron-sized beads (1 µm) that act as local magnetic field 
gradient concentrators to magnetize and attract the smaller particles 
when exposed to an external magnetic field. Finally, none of the 
previous studies have considered the diffusion of blood components 
to the buffer solution as they flow side-by-side inside the channel, 
which degrades the quality of the biofluid. Therefore, achieving high 
bead recovery while minimizing blood loss or dilution and avoiding 
diffusion between fluid phases remains a technological challenge. 
It should be noted that these previous studies, including the current 
work, focus on positive magnetophoresis. This method exploits the 
different magnetic properties (susceptibility values) between the 
particles and the surrounding fluid, including the cells present in 
blood. Positive magnetophoresis has been extensively applied for 
separating paramagnetic, ferromagnetic or superparamagnetic 
particles suspended in non-magnetic fluids, including biofluids, and 
especially, in batch separators.25-27 In this case, the particles are 
attracted to the magnetic field as the surrounding media is 
diamagnetic. 
However, there is another magnetic separation technique called 
negative magnetophoresis in which non-magnetic materials 
(including beads, bacteria, cells, etc.) are manipulated from magnetic 
fluids (ferrofluids or solutions of paramagnetic salts such as 
manganese or gadolinium solutions).27 In this case, the target 
components can be considered as “magnetic holes” and are repelled 
from the magnetic field towards an area of field minima.28 This 
technique is very interesting from a clinical point of view, since 
harmful bacteria could be separated from blood in a label-free 
manner (no incubation would be required prior to the 
magnetophoretic processing). Nonetheless, its application for blood 
detoxification is potentially limited for several reasons. 
First, compatible magnetic solutions should be synthesized (for 
example, MgCl2 solutions commonly used in diamagnetophoresis are 
non-biocompatible at the concentration levels required for cell 
separation). In addition, blood is complex and comprised of billions 
of cells with sizes that range between 5-15 µm.28 Some of these cells 
might separate from the blood sample and migrate along with the 
target biomolecules towards their outlet, as the separation is based 
mostly on differences in size. Finally, the magnetic fluid cannot be 
reintroduced into the patient and therefore, post-processing stages 
would need to be applied in order to restore blood properties and 
components. However, this method has proven to be very efficient 
for diagnostics and clinical research (i.e. detection and isolation of 
circulating tumor cells, HeLa cells, sickle red blood cells, bacteria, 
etc.).28-32 More information about the fundamental differences 
between both techniques can be found in Ref. 27. 
The progress of positive magnetophoresis technology as applied in 
blood detoxification requires the following; (a) the complete capture 
of the magnetic bead-toxin complexes using appropriate nonuniform 
magnetic fields (i.e. those that exhibit a gradient in the field 
distribution) and (b) the control of the neighboring coflowing fluids 
(blood and buffer) without intermixing the two inside the device. 
In this article we introduce a CFD-based Eulerian-Lagrangian 
computational model for predicting the overall performance of a 
two-phase liquid-liquid microfluidic separator. The model predicts 
fluid flow within a fixed-mesh Eulerian framework, magnetic particle 
dynamics using a Lagrangian formulation, and mass transfer, i.e. 
blood diffusion to the buffer phase, using Fick’s law. It takes into 
account the dominant magnetic and hydrodynamic forces on the 
particles as well as fully-coupled particle-fluid interactions that give 
rise to interparticle hydrodynamic coupling and particle motion-
induced mixing of the coflowing fluids. We use the model to study 
the performance of a prototype microfluidic device with a Y-Y (input-
output) flow configuration that has been employed for the recovery 
of magnetic beads from a flowing blood solution, as depicted in Fig. 
1. Specifically, we investigate the recovery of micron-sized magnetic 
beads from human whole blood and their collection into an aqueous 
buffer. 
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Fig. 2 Magnetic bioseparation system: (a) Schematics of the magnet-channel system showing device geometry and magnetization. Note that 
the center of the magnet is not aligned with the center of the channel. (b) View of the microfluidic bioseparator showing the coordinate 
system, with an origin at the center of the microchannel for all simulations. 
 
This work includes an analysis of bead dynamics, flow patterns, and 
mixing of the co-flowing blood and buffer fluids. The impact of 
different process variables - flowrates, bead and magnet dimensions 
and fluid viscosities - on bead recovery is quantified for the first time. 
We also characterize the device performance using fluorescence 
microscopy and use this data to validate the model. The 
experimental results are compared with corresponding theoretical 
predictions and found to be within an absolute error of 15%. The 
modeling approach is summarized below and a more detailed 
discussion of the theory can be found in our previous works. 25,33-35 
Finally, the model is well-suited for parametric analysis and 
optimization, thereby facilitating the development of novel 
microfluidic systems, not only for blood detoxification, but also for 
many other applications that utilize magnetophoresis such as 
bioseparation, sorting, sensing and drug discovery, etc. 
 
Computational model 
Modeling Approach 
In this section we summarize key details of the computational model. 
The model was developed by customizing a commercial multiphysics 
CFD software program, FLOW-3D from Flow Science Inc. (ver11.2, 
www.flow3d.com). Specifically, custom magnetic field and force 
algorithms were integrated into the program to predict the field 
distribution from various field sources and the corresponding force 
on magnetic particles. FLOW-3D has two preprogrammed models, 
the “Particle” and “General Moving Object” (GMO) models that 
predict particle dynamics taking into account various forces (e.g. 
hydrodynamic and gravitational) and coupled particle-fluid 
interactions (i.e. two-way momentum transfer) wherein the moving 
particles perturb the flow field. However, as of this writing, the 
program had no magnetic analysis capability, which is what we 
added. FLOW-3D solves for fluid flow (Navier-Stokes equations) 
using a Volume of Fluid (VOF), finite-difference based, Eulerian fixed 
grid approach, while a Lagrangian framework is used to model 
particle dynamics within the fluid. The model is based on the 
following assumptions: (a) all fluids are Newtonian and 
incompressible (blood is often assumed to be Newtonian with a 
viscosity value between 3 and 4 cP for medium to high shear 
rates),25,36 (b) the magnetic particles have a linear magnetization 
curve with saturation, (c) interparticle magnetic dipole-dipole 
coupling is negligible because of a low particle concentration, (d) the 
field sources are ideal 3D rare-earth permanent magnets, and (e) 
there are no other magnetic materials present in the computational 
domain that would otherwise perturb the magnetic field. This last 
assumption is important as it allows for the use of analytical 
expressions for the magnetic field distribution and force. This 
eliminates the need for numerical field predictions, which greatly 
simplifies the analysis and reduces simulation time. 
Magnetic analysis 
We use a Lagrangian approach to predict the motion of the magnetic 
beads. In this analysis the beads are modeled as discrete objects and 
their trajectories are predicted in accordance with classical 
Newtonian dynamics:27 
 
𝐦𝐦𝐩𝐩
𝐝𝐝𝐝𝐝𝐩𝐩
𝐝𝐝𝐝𝐝
= ∑𝐅𝐅𝐞𝐞𝐞𝐞𝐝𝐝                                                  (1) 
 
Here, mp and vp are the mass and velocity of a bead and Fext 
represents all external force vectors exerted on it. 
As previously noted, FLOW-3D has various forces preprogrammed, 
but not the magnetic force. We modeled the magnetic force Fm 
acting on a bead using the “effective” dipole moment method in 
which the bead is replaced by an “equivalent” point dipole with a 
moment mp,eff at its center as described by Furlani.18,25,27,37 Fm is given 
by: 
 
𝐅𝐅𝐦𝐦 = 𝛍𝛍𝟎𝟎�𝐦𝐦𝐩𝐩,𝐞𝐞𝐞𝐞𝐞𝐞 · 𝛁𝛁�𝐇𝐇𝐚𝐚                                    (2) 
 
where 𝛍𝛍𝟎𝟎 represents the permeability of the free space (4π·10-7 H·m-
1) and Ha is the applied magnetic field intensity at the center of the 
bead. The moment mp,eff can be determined using a magnetization 
model that takes into account self-demagnetization and magnetic 
saturation of the beads: 
 
𝐦𝐦𝐩𝐩,𝐞𝐞𝐞𝐞𝐞𝐞 = 𝐕𝐕𝐩𝐩𝐞𝐞(𝐇𝐇𝐚𝐚)𝐇𝐇𝐚𝐚                                     (3) 
 
where the function f(Ha) is calculated as follows: 
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 𝐞𝐞(𝐇𝐇𝐚𝐚) = 𝛘𝛘𝐩𝐩,𝐞𝐞              ∀            |𝐇𝐇𝐚𝐚| < ��𝐞𝐞𝐩𝐩−𝐞𝐞𝐞𝐞�+𝟑𝟑𝟑𝟑�𝐞𝐞𝐩𝐩−𝐞𝐞𝐞𝐞� � 𝐌𝐌𝐬𝐬,𝐩𝐩                       (4) 
   𝐞𝐞(𝐇𝐇𝐚𝐚) =  𝐌𝐌𝐬𝐬,𝐩𝐩|𝐇𝐇𝐚𝐚|               ∀            |𝐇𝐇𝐚𝐚| ≥ ��𝐞𝐞𝐩𝐩−𝐞𝐞𝐞𝐞�+𝟑𝟑𝟑𝟑�𝐞𝐞𝐩𝐩−𝐞𝐞𝐞𝐞� �𝐌𝐌𝐬𝐬,𝐩𝐩                     (5) 
                               
where Vp is the volume of a spherical bead of radius rp, 𝛘𝛘𝐩𝐩,𝐞𝐞 is the 
effective susceptibility of the bead that can be related to the intrinsic 
susceptibility38,39 and Ms,p represents the saturation magnetization 
of the beads.  
Thus, the expression for Fm takes into account conditions both below 
and above the saturation of the bead as a function of the external 
applied field and can be written as: 
 
𝐅𝐅𝐦𝐦 = 𝛍𝛍𝟎𝟎𝐕𝐕𝐩𝐩𝐞𝐞(𝐇𝐇𝐚𝐚)(𝐇𝐇𝐚𝐚 · 𝛁𝛁)𝐇𝐇𝐚𝐚                             (6) 
 
In order to solve Eq. (6), an expression is needed for the field 
distribution generated by an external rare-earth magnet. The field 
and gradient produced by the magnet depend on its material 
properties, shape and dimensions. Three different commercially 
available rectangular-shaped rare-earth magnets were used for this 
study. These have dimensions LxHxW equal to 5x5x3, 8x8x4 and 
10x5x3 mm3, respectfully. 
To determine the 3D field distribution of the magnets, we employed 
an analytical model developed by Furlani.40 It should be noted that 
we can use an analytical field expression because we have assumed 
that there are no other magnetic materials in the computational 
domain, which is true for the prototype system that we study. A 
closed-form expression for calculating the field of the magnet 
geometry shown in Fig. 2a, with its magnetization in the z direction, 
is: 
 
𝐁𝐁𝐞𝐞 (𝐞𝐞, 𝐲𝐲, 𝐳𝐳) =  𝛍𝛍𝟎𝟎𝐌𝐌𝐬𝐬𝟒𝟒𝟒𝟒 ∑ ∑ (−𝟏𝟏)𝐤𝐤+𝐦𝐦 𝐥𝐥𝐥𝐥 �(𝐲𝐲−𝐲𝐲𝟏𝟏)+�(𝐞𝐞−𝐞𝐞𝐦𝐦)𝟐𝟐+(𝐲𝐲−𝐲𝐲𝟏𝟏)𝟐𝟐+(𝐳𝐳−𝐳𝐳𝐤𝐤)𝟐𝟐�𝟏𝟏𝟐𝟐(𝐲𝐲−𝐲𝐲𝟐𝟐)+�(𝐞𝐞−𝐞𝐞𝐦𝐦)𝟐𝟐+(𝐲𝐲−𝐲𝐲𝟐𝟐)𝟐𝟐+(𝐳𝐳−𝐳𝐳𝐤𝐤)𝟐𝟐�𝟏𝟏𝟐𝟐�𝟐𝟐𝐦𝐦=𝟏𝟏𝟐𝟐𝐤𝐤=𝟏𝟏                    (7) 
       
𝐁𝐁𝐲𝐲 (𝐞𝐞, 𝐲𝐲, 𝐳𝐳) = 𝛍𝛍𝟎𝟎𝐌𝐌𝐬𝐬𝟒𝟒𝟒𝟒 ∑ ∑ (−𝟏𝟏)𝐤𝐤+𝐦𝐦𝟐𝟐𝐦𝐦=𝟏𝟏𝟐𝟐𝐤𝐤=𝟏𝟏 𝐥𝐥𝐥𝐥�(𝐞𝐞−𝐞𝐞𝟏𝟏)+�(𝐞𝐞−𝐞𝐞𝟏𝟏)𝟐𝟐+(𝐲𝐲−𝐲𝐲𝐦𝐦)𝟐𝟐+(𝐳𝐳−𝐳𝐳𝐤𝐤)𝟐𝟐�𝟏𝟏𝟐𝟐(𝐞𝐞−𝐞𝐞𝟐𝟐)+�(𝐞𝐞−𝐞𝐞𝟐𝟐)𝟐𝟐+(𝐲𝐲−𝐲𝐲𝐦𝐦)𝟐𝟐+(𝐳𝐳−𝐳𝐳𝐤𝐤)𝟐𝟐�𝟏𝟏𝟐𝟐�                   (8) 
   
𝐁𝐁𝐳𝐳 (𝐞𝐞,𝐲𝐲, 𝐳𝐳) = 𝛍𝛍𝟎𝟎𝐌𝐌𝐬𝐬𝟒𝟒𝟒𝟒 ∑ ∑ ∑ (−𝟏𝟏)𝐤𝐤+𝐥𝐥+𝐦𝐦𝟐𝟐𝐦𝐦=𝟏𝟏 𝐞𝐞 𝐝𝐝𝐚𝐚𝐥𝐥−𝟏𝟏𝟐𝟐𝐥𝐥=𝟏𝟏𝟐𝟐𝐤𝐤=𝟏𝟏 � (𝐞𝐞−𝐞𝐞𝐥𝐥)(𝐲𝐲−𝐲𝐲𝐦𝐦)(𝐳𝐳−𝐳𝐳𝐤𝐤)�(𝐞𝐞−𝐞𝐞𝐥𝐥)𝟐𝟐+(𝐲𝐲−𝐲𝐲𝐦𝐦)𝟐𝟐+(𝐳𝐳−𝐳𝐳𝐤𝐤)𝟐𝟐�𝟏𝟏𝟐𝟐�         (9) 
 
Here, Ms is the saturation magnetization of the magnet, i.e. 106 A·m-
1, which was estimated based on experimental magnetic field 
measurements using a custom MatLab program. In the field 
equations, x1=L-/2, x2=L/2, y1=-H/2, y2=H/2, z1=-W/2 and z2=W/2 
represent one half of the magnet’s dimensions (L, H and W) in the x, 
y and z directions, respectively, when the coordinate system 
centered with respect to the center of the magnet. It should be noted 
that in our subsequent device performance analysis we use a 
coordinate system that is centered at the center of the microchannel, 
as presented in Fig. 2b. Given the expressions for the field 
components, we can determine the magnetic force on a particle at 
any point in the domain. 
 
 
Hydrodynamic force 
The hydrodynamic force Fhd on the beads is predicted numerically 
using the following expression:  
 
𝐅𝐅𝐡𝐡𝐝𝐝 = −𝐕𝐕𝐩𝐩𝛁𝛁𝛁𝛁 + 𝐌𝐌𝐚𝐚𝐝𝐝𝐝𝐝𝐞𝐞𝐝𝐝 �𝐝𝐝𝐝𝐝𝐝𝐝𝐝𝐝 − 𝐝𝐝𝐝𝐝𝐩𝐩𝐝𝐝𝐝𝐝 � + 𝐅𝐅𝐝𝐝𝐝𝐝𝐚𝐚𝐝𝐝                        (10) 
 
where P is the pressure, Madded is the added mass (additional 
resistance for an accelerating or decelerating body), v is the fluid 
velocity at the location of the particle and Fdrag is the drag force acting 
on the beads. The amount of added mass can be calculated using the 
following equation: 
 
𝐌𝐌𝐚𝐚𝐝𝐝𝐝𝐝𝐞𝐞𝐝𝐝 = 𝐂𝐂𝐌𝐌𝛒𝛒𝐕𝐕𝐩𝐩                                       (11) 
 
where the coefficient CM is theoretically predicted to be equal to 0.5 
and ρ is the fluid density.41 
Finally, the drag force Fdrag can be obtained using a modified form of 
Stokes’ approximation for the drag on a sphere: 
 
𝐅𝐅𝐝𝐝𝐝𝐝𝐚𝐚𝐝𝐝 = 𝟏𝟏𝟐𝟐 𝛒𝛒�𝐝𝐝 − 𝐝𝐝𝐩𝐩��𝐝𝐝 − 𝐝𝐝𝐩𝐩�𝐀𝐀𝐩𝐩𝐂𝐂𝐝𝐝                        (12) 
 
where AP is the bead cross sectional area, which can be written as AP 
= πrp2. CD is the drag coefficient for steady-state flow around a sphere 
and can be calculated from: 
 
𝐂𝐂𝐃𝐃 = 𝟐𝟐𝟒𝟒𝐑𝐑𝐞𝐞𝐩𝐩 + 𝟔𝟔𝟏𝟏+�𝐑𝐑𝐞𝐞𝐩𝐩 + 𝟎𝟎.𝟒𝟒                                (13) 
 
where Rep is the particle Reynolds number for which the expression 
is valid.42 More specifically, we have: 
 
𝐑𝐑𝐞𝐞𝐩𝐩 = 𝛒𝛒𝐝𝐝𝐡𝐡�𝐝𝐝−𝐝𝐝𝐩𝐩�𝛈𝛈 < 𝟐𝟐 · 𝟏𝟏𝟎𝟎𝟓𝟓                                   (14) 
 
where dh is the hydraulic diameter and η is the fluid viscosity. 
We investigate the effect of the fluid properties on magnetic 
separation by employing viscous aqueous solutions (η values of 
approximately 0.001 and 0.004 Pa·s) and human whole blood 
(η=0.0035 Pa·s). The buffer solution used as the collecting phase in 
the bioseparator is modeled as water at 20ºC with a viscosity of 0.001 
Pa·s. Finally, to calculate Fhd we need an expression for the fluid 
velocity, which is developed in the next subsection. 
Flow and mass transfer 
The fluid velocity is predicted numerically in FLOW-3D by solving 
modified Navier-Stokes and continuity equations (Eqs. 15 and 16) 
that account for the interactions between fluid and magnetic beads 
(see FLOW-3D user’s manual for details):  
 
𝐝𝐝(𝛒𝛒𝐝𝐝)
𝐝𝐝𝐝𝐝
= −𝛁𝛁𝛁𝛁 + 𝐝𝐝𝐝𝐝𝐝𝐝(𝛕𝛕) + 𝟏𝟏
𝐕𝐕
𝐅𝐅𝛁𝛁                                      (15) 
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𝛁𝛁 · (𝐝𝐝) = 𝟎𝟎                                               (16) 
 
where the div(τ) term represents the viscous accelerations and V is 
the volume of fluid in a computational cell. The last term in Eq. 15 
represents particle induced fluid accelerations and FP is given by: 
 
𝐅𝐅𝛁𝛁 = −∑�𝐅𝐅𝐝𝐝𝐝𝐝𝐚𝐚𝐝𝐝 + 𝐌𝐌𝐚𝐚𝐝𝐝𝐝𝐝𝐞𝐞𝐝𝐝 �𝐝𝐝𝐝𝐝𝐝𝐝𝐝𝐝 − 𝐝𝐝𝐝𝐝𝐩𝐩𝐝𝐝𝐝𝐝 ��                             (17) 
 
These equations are solved numerically using a finite difference-
based Volume of Fluid (VOF) method (see FLOW-3D user’s guide). As 
previously noted, all fluids are assumed to be incompressible. 
In addition, the model also solves the mass transport of a species 
between both phases by solving the continuity equation and Fick’s 
law. The presence of a solute is defined as a property of both fluids 
(advectable scalar) and it is treated as an interstitial solute. The 
advectable scalar in this work is defined as the concentration C, i.e. 
the mass per fluid volume in a cell and the transport equation that is 
solved is given as follows: 
 
𝛛𝛛𝐂𝐂
𝛛𝛛𝐝𝐝
+ 𝟏𝟏
𝐕𝐕𝐞𝐞
(𝐝𝐝𝐀𝐀𝛁𝛁𝐂𝐂) = 𝟏𝟏
𝐕𝐕𝐞𝐞
[𝛁𝛁(𝐀𝐀𝐃𝐃𝛁𝛁𝐂𝐂)]                           (18) 
 
where Vf and A are the fractional volume and area open to flow for 
each mesh cell, respectively, and D is the diffusion coefficient of the 
solute. In this work, we analyze the component diffusion between 
phases through their interface as they flow within the channel 
according to the component’s diffusion time. This time represents 
the time required for partitioning of solutes between the phases and 
is calculated as:43-45 
 
𝐝𝐝𝐝𝐝𝐝𝐝𝐞𝐞𝐞𝐞 =  𝐇𝐇𝐝𝐝𝟐𝟐𝐣𝐣𝐃𝐃                                                        (19) 
 
where Hi is the height of the channel that phase “i” is flowing through 
and “j” represents the number of dimensions in which diffusion takes 
place. Thus, if the residence time exceeds the diffusion time of the 
solute inside the device, the component will have enough time to 
diffuse to the co-flowing phase. Therefore, we study the diffusion at 
different values of the ratio γ, described as follows: 
 
𝛄𝛄 = 𝐝𝐝𝐝𝐝𝐞𝐞𝐬𝐬
𝐝𝐝𝐝𝐝𝐝𝐝𝐞𝐞𝐞𝐞
= 𝐋𝐋𝐜𝐜 𝐣𝐣𝐃𝐃
𝐝𝐝�𝟏𝟏𝐇𝐇𝟏𝟏
𝟐𝟐                                                (20) 
 
where Lc represents the total length of the chip (Lc=2 mm in our 
prototype) and 𝐝𝐝�𝟏𝟏 the average velocity of the phase 1 (inlet velocity), 
whereas H1 is the height of the branch where this phase flows 
(H1=150 µm). 
 
 
 
 
Methodology 
Fig. 2b shows the x-z plane of the microchannel used in the 
simulations. Although the force balance for each bead is solved 
within a 3D analysis (the magnetic field distribution and magnetic 
force is calculated in x, y, and z directions), the governing equations 
for the flow along the width of the channel (y axis) are not 
considered. The channel height (Hc) and length (Lc), in z and x 
directions, are 300 µm and 2 mm, respectively. Hc was modified for 
the simulations of particle recovery from blood as the glass 
microdevice employed for that experiments is 280 µm wide. 
The magnets are positioned at a distance d=200 µm from the lower 
channel wall with the left corner of the magnet placed at the 
beginning of the chip’s straight section, at x=-Lc/2, as shown in Fig. 
2b. This location in x direction was selected due to the higher 
magnetic gradients that occur at that position, and also, because of 
the easier visual positioning under the microscope. Beads enter the 
upper inlet (equally distributed along the diameter), at a constant 
concentration of 0.1 g·L-1 (0.2 g·L-1 for bead recovery from blood), 
and are tracked at every time step. Interbead effects (e.g. magnetic 
dipole-dipole coupling) are neglected due to the low concentration, 
i.e. values in the typical range of relevant detoxification 
studies.4,10,46,47 
The performance of the separator is evaluated through a 
dimensionless number J48 that describes the relationship between 
the magnetic and fluidic drag forces. Thus, the J number scales both 
the magnetic force (in the z direction) and drag force (in the x 
direction, obtained using Stokes’ approximation for the drag on a 
sphere27,49) on the beads located in the middle plane of the channel. 
This location was chosen because of the average value of the 
magnetic force acting at that point. The J number can be written as 
follows: 
 
𝐉𝐉 = 𝐅𝐅𝐦𝐦𝐚𝐚𝐝𝐝,𝐳𝐳��������
𝟔𝟔𝟒𝟒𝐝𝐝𝐩𝐩𝛈𝛈𝟏𝟏𝐝𝐝�𝟏𝟏
                                                       (21) 
 
To calculate J, the magnetic force was calculated at the mid-plane of 
the channel (z=0) for every simulation using a separate MatLab 
program. For computing the denominator of the number, the 
product η1𝐝𝐝�𝟏𝟏 for phase 1 was chosen because the beads are initially 
located in the phase 1 flow, and therefore, when they cross the 
interface and move to the collecting phase, the separation is 
successful. Thus, the numerator of this number provides the average 
Fm,z that pulls the beads downwards, whereas the denominator 
represents the average Fdrag,x acting on the beads during separation. 
As previously noted, the flow field and equations that govern bead 
motion were solved using FLOW-3D. We integrated the magnetic 
analysis, the magnetic field and force, via the development of an 
external Fortran subroutine, which was compiled in Visual Studio 
v.2013 (Microsoft). The subroutine passed the components of the 
magnetic force to FLOW-3D at each time step, which were 
incorporated into the force balance within the bead analysis model. 
Furthermore, MatLab v.2015 (The MathWorks, Inc.) was also used 
for rapid analysis of the magnetic field and force at different points 
of the channel. 
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Fig. 3 Magnetophoretic bioseparation microsystem: (a) SU-8 microfluidic device employed for bead separation from water/ethylene glycol 
solutions; Dimensions: 2 mm long and 300 µm wide with a rectangular cross-section of 300 x 200 µm. (b) Methacrylate holder for the SU-8 
microdevice showing fluidic connections and magnet position. (c) Glass microdevice employed for bead separation from human whole blood; 
Dimensions: 2 mm long and 280 µm wide with a U-shaped cross-section of 280 µm in width and 60 µm in depth. (d) Aluminium holder 
employed for the glass device, showing magnet position and capillary tubing. 
 
Experimental methodology 
The experiments for validating the model with aqueous solutions 
were performed using a prototype SU-8 Y-Y shaped device with a 
rectangular cross-section of 300 µm x 200 µm (Microliquid) as shown 
in Fig. 3a. This chip was placed in a methacrylate holder, and tygon 
tubing (ø=0.8 mm) was employed for the fluidic connections (Fig. 3b). 
For the experiments with human whole blood, a glass microdevice 
with a U-shaped cross-section was employed (Fig. 3c). This device 
was fabricated with conventional photolithography and wet etching 
techniques.50 The glass chip was mounted into an aluminum holder 
and connected to the pumps with fused silica capillaries (150 µm i.d., 
375 µm o.d., Polymicro Technologies). Two syringe pumps (Legato 
210 infuse/withdraw syringe pump, Kd Scientific) and single syringes 
(Omnifix 5mL luer, BRAUN) were used to control the flow. 
For the fluidic analysis, fluids with different characteristics, i.e. two 
different fluid phases, were pumped into the two inlets, respectively: 
a) Phase 1 - Fluorescein sodium salt solution (employed as a coloring 
agent to distinguish the phases), (Scharlau) or human whole blood 
(explained below), and b) Phase 2 - deionized water or a mixture of 
ethylene glycol in water 50% v/v (PanReac AppliChem), that exhibits 
a density and viscosity values similar to human blood (1050 kg·m3 
and 4.1 cP at 20ºC).51 
For the mass transfer analysis, we employed a specific Phase 1 
fluorescein solution (60 mg·L-1, diffusion coefficient for fluorescein in 
water: 4.25·10-6 cm2·s-1),52 whereas deionized water was pumped 
into the phase 2 inlet. To study the possible migration of blood cells 
between the fluid phases, we prepared aqueous solution of non-
magnetic 6-8 µm polystyrene beads (Spherotech, Inc., catalog 
number HISP-60-2) at a concentration of 1 g·L-1. This solution was 
pumped into the upper inlet, whereas deionized water was 
introduced into the device through the lower outlet. Bead 
concentration was measured under the microscope after sample 
collection at the outlets.  
For the magnetic bead recovery analysis, we prepared aqueous 
solutions of fluorescent magnetic beads of two different sizes, i.e. 
2.29 or 4.9 μm in diameter (Spherotech, Inc., catalog numbers FCM-
2052-2 and FCM-4052-2) at a constant concentration of 0.1 g·L-1. To 
evaluate the influence of the fluid viscosity on the bead recovery, 
bead solutions were prepared in ethylene glycol solutions 50% v/v. 
In general, deionized water was pumped into the lower inlet for the 
bead experiments. 
Fig. 4 Magnet characterization and field analysis: (a) Experimental 
and theoretical values of Bz measured at different points above the 
center of the magnet surface (in z direction). (b) Measured Bz in a 
plane x-y at z=1.5 mm. (c) Theoretical predictions for that plane. 
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Fig. 5 Image processing for experimental analysis: (a) Visible image and selection of the chip’s contours; Dashed lines, which delimitate the 
inlets and outlets, are automatically drawn after the user selects the 6 vertices manually. (b) Superimposition of contours over the 
fluorescence image. (c) Green (G) channel enhancement process by removing the noise from the G component. (d) Bead recovery 
quantification by counting green pixels at the outlets. Figs. 5c and 5d are represented in false color.
 
Finally, a set of experiments with human whole blood was performed 
in order to evaluate the device performance under a more realistic 
scenario. Human whole blood from healthy subjects was collected 
with informed consents according to a protocol approved by the 
Advanced Separation Processes Group following the University of 
Cantabria guidelines.  The samples were collected into 3.5 mL tubes 
with anticoagulant (sodium citrate 3.2%) and was processed within 5 
hours of blood draw. Before the experiments, saline buffer (NaCl 9 
mg·mL-1; Fresenius, Kabi) with bemiparin sodium (Hibor®, Rovi 
Pharmaceuticals Laboratories) was pumped into the device through 
both inlets for 10 minutes. For the co-flow experiments, blood was 
loaded into a 2-mL syringe and injected into the glass device at 
different flow rates. For the magnetic bead recovery, blood was 
spiked with the 4.9 µm magnetic beads at a concentration of 0.2 g·L-
1. Saline buffer was introduced into the device through the lower 
outlet for both studies. The syringes were agitated every 5-10 
minutes in order to prevent blood cells from settling. 
Although the size of the magnetic beads employed in this work was 
specified from the manufacturer, the susceptibility and saturation 
(𝛘𝛘𝐩𝐩,𝐞𝐞, Ms,p) were not available. We performed a parametric 
estimation of these values from an experimental test and found that 
the saturation magnetization has more impact on the device 
performance. The values obtained were Ms,p = 1.5·104 A·m-1 and 𝛘𝛘𝐩𝐩,𝐞𝐞 
= 0.25, which fall within the range of beads employed for similar 
bioapplications.53,54 The magnetic field was provided by rectangular 
magnets (5x5x3, 8x8x4, 10x5x3 mm3; Supermagnete, Germany). 
They were made from grades 45N-52N neodymium iron boron 
(NdFeB), with remnant magnetizations of Br=1.32-1.47 T. Although 
the company specifies the range of the saturation magnetization of 
the magnets, we nevertheless estimated the actual value from field 
measurements using an analytically based MatLab model. More 
specifically, the magnetic field produced by one of our magnets was 
characterized using a 3D magnetic field mapping instrument, the 
MMS-1-R from SENIS GmbH (www.senis.ch). A three-dimensional 
probe was used to scan the magnetic field at different z values above 
the center of the upper surface of magnet (Bx, By =0 at that points), 
and these values were employed for the estimation of the saturation 
(Fig. 4a). A value of 1013.1 kA·m-1 was obtained and used for all the 
simulations. The theoretical predictions are in excellent agreement 
with the measured data as seen in Figs. 4b and 4c where the 
comparison between them is shown for an x-y plane at z=1.5 mm 
from the magnet surface. 
Fluorescence intensity caused by the presence of fluorescein or 
beads in the fluid phases was detected using a microscope (Nikon 
SMZ18) equipped with a green fluorescence filter (light wavelengths 
of around 550 nm) and a Jenoptik ProgRes C5 camera. Images were 
taken using the ProgRes® CapturePro software (CapturePro 
V2.10.0.0). Whereas the analysis of the flow patterns and diffusion 
phenomena was easily performed by analyzing the photographs 
taken with the camera (fluorescein diffusion is even visible to the 
naked eye), it was not possible to quantitatively calculate the bead 
separation effectiveness from the photographs. Therefore, we 
developed a custom code for image analysis using MatLab. The 
image processing is shown step-by-step in Fig. 5. Firstly, the user 
selects the vertice points delimiting the input and output channels 
using an image of the microchip taken under visible light (Fig. 5a). 
These points are used to delimit the channels in the following images 
taken under fluorescence light, and the channel limits are 
superimposed for visual assessment (Fig. 5b). 
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Fig. 6 Flow analysis: (a) Simulation and (b) experimental results of flow patterns of two aqueous solutions flowing at the same flow rate (0.15 
µL·s-1). (c) and (d) Flow patterns of fluorescein (aqueous) and ethylene glycol solutions when the pressure drop for both phases is fixed along 
the channel length. (e) Flow patterns of human whole blood and saline buffer at flow rates of 1 and 2.75 µL·s-1. (f) Sample collection at the 
outlets when the flow rates are 1 and 1 µL·s-1 (mixing at the outlet 2 is reported as blood exits through both outlets) and 1 and 2.75 µL·s-1 
(for this condition no blood loss is reported). 
 
From the fluorescent image, the code automatically splits the color 
components (Red (R), Green (G), and Blue (B)). Afterwards, the 
program enhances the G component (as fluorescence is emitted in 
green) by removing the R component that generates noise in the 
images (Fig. 5c). At this point, an intensity threshold is established 
and manually tuned until the pixels detected in the clean G 
component correspond to the beads inside the channel (Fig. 5d). 
Finally, the code accounts for the number and area of beads that exit 
the channel through each outlet in the Y junction by counting the 
areas of green pixels detected in the outlets. Thus, the experimental 
bead recovery can be estimated as follows: 
 
𝐁𝐁𝐞𝐞𝐚𝐚𝐝𝐝 𝐝𝐝𝐞𝐞𝐜𝐜𝐫𝐫𝐝𝐝𝐞𝐞𝐝𝐝𝐲𝐲 =  𝐀𝐀𝐝𝐝𝐞𝐞𝐚𝐚𝟓𝟓−𝟔𝟔 
𝐀𝐀𝐝𝐝𝐞𝐞𝐚𝐚𝟒𝟒−𝟓𝟓+𝐀𝐀𝐝𝐝𝐞𝐞𝐚𝐚𝟓𝟓−𝟔𝟔
· 𝟏𝟏𝟎𝟎𝟎𝟎                   (22) 
 
It should be noted that we have checked the accuracy of the 
developed method by comparing the calculated recovery of the 
beads (measured with the software) and the concentration 
measured at the outlets after sample collection and processing for 
one of the experimental tests of this work. We found that the results 
obtained with both methods differ by less than 10%, which validates 
the accuracy of our customized image processing program. Since this 
method has been automatized, once the picture of the device is 
taken, it takes only 10 seconds to obtain the recovery percentage of 
the device, in comparison to the sample collection, bead re-
concentration and measurement process, which is much more 
tedious and time consuming. Furthermore, it can be used for real-
time process monitoring and even integrated into a control loop for 
optimization, as a consequence of the continuous mode of the 
process. 
For each experimental condition, different tests were performed and 
an average of 5 different micrographs were taken and analyzed. The 
value reported in the results section represents the average 
recovery. Nonetheless, for the experiments with human whole 
blood, the bead recovery was calculated by measuring bead 
concentration at the outlets after sample collection, since the high 
concentration of blood cells might interfere with the illumination of 
the beads in the upper branch and lead to different fluorescence 
intensity values in comparison with the co-flowing aqueous solution. 
 
Results and discussion 
Fluid phase flow patterns and mass transfer 
In this section, the flow patterns of phases with the same and 
different fluid properties are analyzed in order to examine the flow 
conditions that lead to the complete separation of the fluids at the 
bioseparator outlets. Furthermore, we study the flow conditions that 
maximize and minimize the interdiffusion between streams. 
In Figs. 6a and 6b, the volumetric fraction occupied by aqueous 
phases (fluorescein solution – deionized water) inside the device 
when the flow rates are the same is presented. When both phases 
flow through the channel at the same mean velocity (set in this case 
at ≈ 0.5 cm·s-1), independent co-flow of the phases is achieved and 
mixing at the outlets is not observed. Furthermore the experimental 
images are in agreement with our theoretical predictions as seen in 
Fig. 6b. When a more viscous solution was pumped into the channel, 
i.e. fluorescein solution – ethylene glycol 50% v/v mixture or human 
blood – saline buffer, such behavior is not observed. However, as 
demonstrated in our previous work,48 when the two fluids have a 
different viscosity there is a negative impact on the co-flow and 
phase separation. 
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Fig. 7 Fluorescein mass transfer at different γ values: (a) Simulated results and (b) experimental micrograph for γ≈1 (showing the downstream 
positions x=-1, 0 and 1 mm where the fluorescence intensity analysis was carried out). (c) Measurements of fluorescence intensity across the 
channel width at the 3 downstream locations showed in (b). (d) Simulated results and (e) experimental micrograph for γ≈0.01. (f) 
Measurements of fluorescence intensity across the channel width at the same downstream locations.  
 
This is because the difference in viscosities between the fluids 
creates different pressure gradients in the respective branches of the 
channel, which then translated into the mixing at the outlets. 
Nevertheless, this can be minimized by ensuring the same pressure 
drop in each phase throughout the length of the channel. With the 
Hagen Poiseuille law the separation can be improved when the 
product (η𝐝𝐝�)i for each phase i is the same. Figs. 6c and 6d show the 
fluorescein – ethylene glycol separation at the outlets when this 
criterion was applied (average fluid velocities at inlets are 0.5 cm·s-1 
and 2.1 cm·s-1 for ethylene glycol and water solutions, respectively). 
Furthermore, Fig. 6e shows the blood-buffer co-flow when the saline 
buffer is pumped at a flow rate almost 3 times higher than blood, and 
Fig. 6f demonstrates how the separation is substantially improved 
using this criterion in comparison with the use of the same flow rates 
for both fluids. This behavior was also observed in other 
studies.23,55,56 
When working with complex and multicomponent solutions 
(biological fluids such as blood), not only the solution loss or dilution 
at the outlet should be analyzed, but also, the possible diffusion of 
its constituents to the buffer solution. We analyzed the diffusion of 
fluorescein from phase 1 to phase 2 as a function of γ (ratio between 
residence and diffusion times as presented in Eq. (20)). In Fig. 7a we 
show the simulation of fluorescein diffusion for γ values close to 1. In 
this case, the residence time is approximately equal to the diffusion 
time (≈ 40 s) and the fluorescein has time to completely diffuse to 
phase 2. Thus, the mass transfer under this velocity condition is 
complete as the concentration reported at both outlets is the same 
(30 mg·L-1), which is half of the initial value at the phase 1 inlet (60 
mg·L-1). As can be seen from the experimental image (Fig. 7b), the 
fluorescence intensity at the lower outlet is approximately the same 
as that reported at the upper outlet. We calculated the change in the 
fluorescence intensity across the channel width for different 
downstream positions x=-1, 0 and 1 mm (Fig. c). The plot 
demonstrates the diffusion phenomena for γ≈1 as the fluorescence 
intensity across the width drastically varies at the interface for x=-1 
mm (inlet), but a small reduction in the value is found for the 
positions x=0 and x=1 mm (the intensity fluorescence across the 
width almost remains constant at x=1 mm). The different intensity 
fluorescence at channel width equal to 0 for the three x positions 
might be due to the inhomogeneous illumination conditions inside 
the device. In Figs. 7d and 7e we show the diffusion of fluorescein for 
γ values close to 0.01. In this case, the residence time is much lower 
than the diffusion time (≈ 0.4 s) and the fluorescein diffusion from 
phase 1 to phase 2 is neglected. As seen from the simulation (Fig. 7d), 
the fluorescein concentration at the lower outlet is around 6 mg·L-1, 
80% lower than the value reported when γ was approximately 1. 
Furthermore, the fluorescence intensity at the lower outlet is not 
perceived from the experimental image (Fig. 7e). For this γ value, a 
sharp change in the fluorescence intensity is reported at the 
interface between both fluid phases for all downstream positions 
due to the low diffusion reported between streams as perceived 
from Fig. 7f. 
Finally, the migration of big macromolecules was investigated by 
using non-magnetic polystyrene beads. We employed beads with 
sizes of approximately 7 µm and observed their trajectories along the 
device. This is important as it provides some insight as to the 
transport of blood components, such as red blood cells (6-9 µm) or 
white blood cells (8-14 µm).28 We simulated the trajectory followed 
by these 7 µm polystyrene beads (a flow rate range of 0.005-0.5 µL·s-
1 was studied and no difference was observed over this range). The 
beads followed the fluid streams depicting a straight line from the 
inlet to the outlet, i.e. no deflection was found for any of the flow 
rates tested. This result is in good agreement with our experimental 
data and also expected under these flow conditions, since the 
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diffusion coefficient of macromolecules of that size (blood cells) is 
around 10-14 m2·s-1 as calculated by the Stokes-Einstein equation. 
Thus, working with γ values of approximately 0.01, the diffusion of 
relatively small molecules (such as fluorescein) and big 
macromolecules (blood proteins or cells) can be considered 
negligible due to their low diffusivity value, and thus, high diffusion 
time (the diffusion time increases up to several minutes for these 
macromolecules,48,57 whereas the residence time of our fluid phases 
inside the bioseparator is less than 4 seconds for all the experiments 
performed for studying the magnetophoresis). Therefore, it can be 
assured that diffusion of blood components to the buffer solution is 
negligible at the time scales of interest. 
 
Bead magnetophoresis 
In this section the recovery of magnetic beads is analyzed under 
different magnetic field and fluid flow conditions. Different variables 
(flow rates) and parameters (magnet and bead dimensions, as well 
as the rheological properties of the phases involved) are studied in 
order to optimize the force balance acting on the beads. 
Influence of magnet dimensions 
The influence of the magnet dimensions on the magnetic field and 
force in the microchannel was studied using three different-sized 
magnets: 5x5x3 mm3; 8x8x4 mm3 and 10x5x3 mm3. The magnetic 
field in z direction provided by the three magnets inside the 
microchannel is analyzed in Table 1, for a x-y plane (limited by the 
chip contours) located at the midline of the channel, i.e. z=0. The 
magnetic force in z direction generated on 2.29 µm and 4.9 µm beads 
with the three magnets at the same plane is also reported in Table 1. 
Only the z component of the field and force is presented since it is 
the component that causes bead deflection from phase 1 to phase 2. 
As reported in Table 1, the magnetic field generated in the channel 
is nonuniform, with values that range from -10 to 40 mT (5x5x3 
mm3), from -20 to 40 mT (8x8x4 mm3) and from -25 to 25 mT 
(10x10x5 mm3). Although these values are not equal, the difference 
between the positive and the negative values is practically the same, 
so the magnetic gradient is very similar for the three structures. This 
is verified by examining the magnetic force generated by those 
magnets on the beads. In this case, the magnetic force acting on the 
4.9 µm beads ranges from -0.1 to -0.22 nN for the 5x5x3 mm3 
magnet, and from -0.1 to -0.24 nN for the 8x8x4 mm3 and 10x10x5 
mm3 magnets. Therefore, the magnetic bead recovery is expected to 
increase slightly as the magnet size increases due to the higher 
magnetic force. 
Following the magnetic field and force analysis, bead separation 
under conditions of variable hydrodynamic forces with the magnetic 
force held fixed is discussed. In Figs. 8a, 8b and 8c, the theoretical 
and experimental bead recovery (4.9 µm beads) from aqueous 
solutions as a function of the applied flow rate is presented for the 
5x5x3 mm3, 8x8x4 mm3 and 10x5x3 mm3 magnets, respectively. As 
seen in the figures, and due to the similar magnetic force generated 
by the 3 magnets, the bead recovery slightly increases with the size 
of the magnet, i.e. the theoretical bead separation increases an 
average of 13% when the 5x5x3 mm3 magnet is replaced by the 
8x8x4 mm3 or the 10x5x3 mm3 magnets. 
Table 1 Magnetic field range (in z direction) inside the SU-8 chip and 
magnetic force range acting on the 2.29 and 4.9 µm beads for each 
magnetic structure employed in this study. 
Magnet 
system 
(mm3) 
Magnetic field 
inside the chip 
(mT) 
Magnetic force 
on 2.29µm 
beads (pN) 
Magnetic force 
on 4.9µm 
beads (nN) 
5x5x3  From -10 to 40 From -10 to -24 From -0.1 to -0.22 
8x8x4  From -20 to 40 From -10 to -25 From -0.1 to -0.24 
10x5x3  From -25 to 25 From -10 to -24 From -0.1 to -0.24 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8 Magnetic bead recovery for 4.9 μm beads (in the SU-8 
microdevice) showing experimental (Fig. 8a) and simulated (Fig. 8b 
and 8c) result images from aqueous solutions as a function of the 
applied flow rate: (a) 5x5x3 mm3 magnet; (b) 8x8x4 mm3 magnet; (c) 
10x5x3 mm3 magnet. 
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For each figure, the magnetic force is kept constant for all the flow 
rates. However, the hydrodynamic force increases with the flow 
rates and when this value is higher than 1.1 µL·s-1, bead recovery 
decreases by as much as 25%. Note that the experimental recovery 
is around 13%, 15% and 26% for the 5x5x3 mm3, 8x8x4 mm3 and 
10x5x3 mm3 magnets, respectively. For these flow rates, the ratio J 
between magnetic and fluidic drag forces is around 0.1. On the other 
hand, as the flow rate is reduced, the magnitude of the fluidic drag 
force decreases as well, and for values equal to 0.25 µL·s-1, the J ratio 
ranges from 0.64 to 0.81 (depending on the magnet). Under these 
low velocity conditions, bead recovery increases up to 89%  for the 
5x5x3 mm3 magnet and up to 100% for the 8x8x4 mm3 and 10x5x3 
mm3 magnets. 
Furthermore, the simulated results follow the same trend as the 
experimental ones although there is a deviation between the two at 
some points of the curves for the 5x5x3 mm3 and 8x8x4 mm3 
magnets. The difference between the experimental and simulated 
results might be caused by the inhomogeneous illumination 
conditions inside the device for each experiment or by an error in the 
image analysis. However, in almost all cases there is a satisfactory 
global value with an absolute error around 15%. 
Influence of bead size 
As presented in Eqs. (3) and (12-14), the bead size affects the fluidic 
drag force (proportional to the bead radius) and the magnetic force 
(proportional to the bead volume). Therefore, we analyzed the 
influence of bead size (i.e. the 2.29 and 4.9 μm beads) on magnetic 
recovery. Firstly, we simulated the magnetic force field acting on the 
beads (Table 1) inside the SU-8 chip. From this table, it can be seen 
that the magnetic force (in the z direction) is reduced by one order 
of magnitude when the bead size is reduced to half. This reduction in 
the magnetic force greatly affects the magnetic recovery. 
In Fig. 9, the magnetic recovery of both bead types as a function of 
the applied flow rate is presented. As plotted in the figure, only 20% 
of the smaller beads are recovered from the solution for flow rates 
as small as 0.25 µL·s-1.  
 
 
 
 
 
 
 
 
 
Fig. 9 2.29 and 4.9 μm magnetic bead recovery (theoretical and 
experimental results) in the SU-8 chip from aqueous solutions as a 
function of the applied flow rate for the 10x5x3 mm3 magnet. 
This is because for these conditions, the ratio J takes values smaller 
than 0.1. It should be noted that this J value for the bigger beads is 
obtained for flow rates higher than 1.3 µL·s-1. Whereas the magnetic 
force is diminished by one order of magnitude for the 2.29 μm beads, 
the drag force is approximately reduced by half, but remains at the 
same order of magnitude as compared to 4.9 μm beads. The 
different force balance acting on both beads explains the different 
recovery ratios. For the 2.29 μm beads, the separation decreases 
between 20% and 77% for the flow rate range under analysis, and 
only by using flow rates smaller than 0.1 µL·s-1, full recovery can be 
achieved. Finally, there is a good agreement between the theoretical 
predictions obtained with the CFD model and the experimental data, 
with an absolute error lower than 10%. 
Influence of viscosity 
In this subsection we analyze the effect of the rheology of the 
biofluids by deflecting the beads from a blood mimicking fluid 
(ethylene glycol mixture 50% v/v) and from human whole blood, 
named in this subsection as “BMF” and “HWB”, respectively. 
In Fig. 10 the separation of 4.9 μm beads from both aqueous and 
BMF solutions is presented for the SU-8 microdevice. By comparing 
both scenarios, we find that the separation is negatively affected 
when a more viscous solution is employed as phase 1. This is due to 
the drag force, proportional to the viscosity of the solution, which 
implies that this force is approximately 4 times higher when BMF 
solutions are treated. For this scenario, bead recoveries of around 
37% are obtained for flow rates of 0.3 µL·s-1 (J ratios smaller than 
0.15), whereas 100% were recovered from water for this flow rate 
value. Higher flow rates of the BMF resulted in bead recoveries lower 
than 30%, values between 23% and 74% lower than the base case in 
which water was employed as phase 1. 
Finally, in Fig. 11 the separation of 4.9 μm beads from both aqueous 
and HWB solutions is presented. It should be first noticed that for 
these experiments, a glass microdevice with a different cross-section 
shape and area was employed, and thus, the flow rates are not 
comparable to the ones presented in Fig. 10. 
 
 
 
 
 
 
 
 
Fig. 10 Magnetic bead recovery (theoretical and experimental 
results) from aqueous and from blood mimicking fluids (BMF) as a 
function of the applied flow rate for the 4.9 μm beads using the 
10x5x3 mm3 magnet and the SU-8 microdevice. 
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Fig. 11 Magnetic bead recovery (theoretical and experimental 
results) from an aqueous solution and from human whole blood 
(HWB) as a function of the applied flow rate for the 4.9 µm beads 
using the 10x5x3 mm3 magnet and the glass microdevice. 
 
As happened with BMF, the separation of these beads from HWB is 
lower than the base case, i.e. in this case, the separation is reduced 
between 22% and 72% when HWB is employed. These values are 
very similar to the ones in which a BMF was employed as phase 1. 
Therefore, to obtain high recovery values from blood solutions, flow 
rates of approximately 0.005 µL·s-1 are required (around six times 
lower than the flow rate required to achieve full separation from 
water in this device as seen in Fig. 11), which correspond to values of 
the J ratio of 1.2. This way the dominant forces acting on the beads 
would remain of the same order of magnitude, which favors the 
recovery. This flow rate results in an average velocity value of 0.65 
mm·s-1 (for this device) with residence times of around 3 s, which is 
still a small value to allow diffusion of blood macromolecules to the 
buffer stream (γ ≈ 0.08 for fluorescein). Therefore, for the separation 
of beads from viscous biofluids such as blood, slower flowrates could 
be safely employed since the integrity of the biofluid will not be 
compromised. 
Finally, it can be seen from Fig. 11 that there is a good agreement 
between the theoretical results and the experimental data (error less 
than 10%), showing the capability of our model to accurately 
describe magnetophoresis from complex fluids as blood. 
 
Conclusions 
In this work, we have introduced a CFD-based computational model 
for analyzing and optimizing magnetic bead separation from 
biological fluids in a liquid-liquid continuous-flow microdevice for 
blood detoxification.  
Our main findings have been systematized in order to meet the three 
technological challenges that should be addressed in real 
detoxification processes. Firstly, the process should be designed so 
that the ratio between the flow rates ensures the same pressure 
drop for both phases along the device length. This way co-flowing of 
streams can be achieved thereby maintaining two completely 
separated phases at the channel outlets. Secondly, the residence and 
diffusion times (γ) should be taken into account in order to evaluate 
possible interdiffusion between streams. For avoiding such 
phenomena, γ value should preferably remain below 0.1. 
Lastly, for the magnetic bead recovery analysis, the effect of 
competing magnetic and hydrodynamic forces has been 
investigated. We showed that these are affected by multiple 
variables and parameters (flow rates, particle size, rheological 
properties of the fluids, etc.) that are highly coupled with each other. 
Consequently, a systematic approach is needed for optimization. We 
showed that key parameters can be integrated into a dimensionless 
number J that scales both forces acting on the beads. The obtained 
data suggests that when the magnetic force is approximately 1.2 
times the fluidic drag force, adequate bead recovery efficacies can 
be reached from human whole blood. Once the conditions that 
satisfy the three requirements have been identified, process design 
(parallelization of the devices as a function of the flow rate of blood 
that needs to be treated) should be carried out. 
Finally, we have validated the model via the analysis of prototype 
devices and have used fluorescence microscopy to characterize key 
performance metrics: flow patterns, mass transfer between 
coflowing fluids and bead separation. The experimental data are 
consistent with the theoretical predictions within an absolute error 
of 15%. Therefore, we conclude that the computational model 
enables understanding of the fundamental underlying mechanisms 
of device performance and is useful for the development of novel 
magnetophoretic applications. In this case, it contributes to the 
development and optimization of magnetic bead separation from 
biological fluids in a multiphase continuous-flow microdevice that 
can potentially be integrated in a two-step system for extracorporeal 
detoxification of biofluids, which will be the focus of our future work. 
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